curcumin has been researched along with Premature-Birth* in 2 studies
1 review(s) available for curcumin and Premature-Birth
Article | Year |
---|---|
Curcumin: Could This Compound Be Useful in Pregnancy and Pregnancy-Related Complications?
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Curcumin; Depression, Postpartum; Dietary Supplements; Female; Fetal Development; Humans; Immunologic Factors; Mice; Models, Animal; Neuroprotective Agents; Phytotherapy; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Rats | 2020 |
1 other study(ies) available for curcumin and Premature-Birth
Article | Year |
---|---|
Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.
A tenet of contemporary obstetrics is that a significant proportion of preterm births involve bacterial infection. Bacterial endotoxin induces pro-inflammatory cytokines, prostaglandins and proteases via the pro-inflammatory pathway nuclear factor-κB (NF-κB), which plays a key role in initiating uterine contractions and rupture of foetal membranes. In non-gestational tissues, the phytophenols curcumin, naringenin and apigenin exert anti-inflammatory properties via inhibition of NF-κB. The aim of this study was to determine whether these treatments regulate pro-inflammatory and pro-labour mediators in human gestational tissues. Placenta, foetal membranes and myometrium were treated with curcumin, naringenin and apigenin in the presence of lipopolysaccharide (LPS) or interleukin (IL)-1β. In placenta and foetal membranes, all treatments significantly reduced LPS-stimulated release and gene expression of pro-inflammatory cytokines IL-6 and IL-8; placenta decreased cyclooxygenase (COX-2) mRNA expression, subsequent release of prostaglandins PGE2 and PGF2α and expression and activity of matrix-degrading enzyme matrix metalloproteinase (MMP)-9. In myometrial cells, all treatments attenuated IL-1β-induced COX-2 expression, release of PGE2 and PGF2α and expression and activity of MMP-9. Although naringenin significantly attenuated IL-1β-induced IL-6 and IL-8 mRNA expression and release, there was no effect of curcumin and apigenin. LPS-stimulated release of 8-isoprostane, a marker of oxidative stress, was attenuated by all treatments. NF-κB p65 DNA-binding activity was also decreased using these treatments. In conclusion, curcumin, naringenin and apigenin exert anti-inflammatory properties in human gestational tissues by inhibiting the transcriptional activity of NF-κB. Further studies should be undertaken to define a possible implication of these natural spices in the management of preterm labour and delivery. Topics: Apigenin; Cells, Cultured; Curcumin; Cyclooxygenase 2; Dietary Supplements; Extraembryonic Membranes; Female; Flavanones; Humans; In Vitro Techniques; Inflammation; Interleukin-6; Interleukin-8; Myometrium; Placenta; Pregnancy; Premature Birth; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factor RelA | 2013 |